Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$848M |
| 2 |
Tesla
TSLA
|
+$759M |
| 3 |
Home Depot
HD
|
+$653M |
| 4 |
Meta Platforms (Facebook)
META
|
+$567M |
| 5 |
Wells Fargo
WFC
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$409M |
| 3 |
Micron Technology
MU
|
+$379M |
| 4 |
AT&T
T
|
+$372M |
| 5 |
Medtronic
MDT
|
+$370M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.03% |
| 2 | Technology | 14.98% |
| 3 | Consumer Discretionary | 11.43% |
| 4 | Consumer Staples | 10.71% |
| 5 | Communication Services | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Scotiabank
BNS
$112B
| $4.47M | 0.01% |
62,300
+46,200
| +287% | +$3.35M |
|
1677
Worthington Enterprises
WOR
$2.87B
| $4.46M | 0.01% |
140,627
-51,835
| -27% | -$1.79M |
|
1678
German American Bancorp
GABC
$1.93B
| $4.45M | 0.01% |
117,248
+6,300
| +6% | +$251K |
|
|
REGI
1679
DELISTED
Renewable Energy Group, Inc.
REGI
| $4.45M | 0.01% |
+73,303
| New | +$3.55M |
|
1680
Caesarstone
CSTE
$119M
| $4.44M | 0.01% |
422,218
-139,782
| -25% | -$1.66M |
|
|
SGMO
1681
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $4.43M | 0.01% |
763,096
-87,600
| -10% | -$521K |
|
|
VNET
1682
VNET Group
VNET
$2.16B
| $4.43M | 0.01% |
759,967
+433,900
| +133% | +$3.33M |
|
1683
Alto Ingredients
ALTO
$324M
| $4.43M | 0.01% |
+649,421
| New | +$3.64M |
|
1684
Funko
FNKO
$344M
| $4.43M | 0.01% |
256,711
-10,832
| -4% | -$189K |
|
1685
Tonix Pharmaceuticals
TNXP
$218M
| $4.42M | 0.01% |
30
+13
| +76% | +$1.99M |
|
1686
Stepan Co
SCL
$1.48B
| $4.42M | 0.01% |
44,700
+41,200
| +1,177% | +$4.46M |
|
1687
Lazard
LAZ
$4.35B
| $4.42M | 0.01% |
128,000
+44,464
| +53% | +$1.72M |
|
|
PW
1688
Power REIT
PW
$2.94M
| $4.42M | 0.01% |
11,210
+680
| +6% | +$388K |
|
|
ESGR
1689
DELISTED
Enstar Group
ESGR
| $4.41M | 0.01% |
+16,900
| New | +$4.48M |
|
|
GNOG
1690
DELISTED
Golden Nugget Online Gaming, Inc. Class A Common Stock
GNOG
| $4.41M | 0.01% |
620,400
+581,700
| +1,503% | +$4.5M |
|
1691
Coeur Mining
CDE
$19.3B
| $4.4M | 0.01% |
988,595
-963,400
| -49% | -$4.59M |
|
1692
10x Genomics
TXG
$7.31B
| $4.4M | 0.01% |
57,800
+40,000
| +225% | +$3.5M |
|
|
TUP
1693
DELISTED
Tupperware Brands Corporation
TUP
| $4.38M | 0.01% |
+225,000
| New | +$3.84M |
|
1694
iShares Russell 2000 ETF
IWM
$82.9B
| $4.37M | 0.01% |
+21,300
| New | +$4.34M |
|
1695
Pebblebrook Hotel Trust
PEB
$2.06B
| $4.37M | 0.01% |
+178,500
| New | +$4.1M |
|
|
BPMC
1696
DELISTED
Blueprint Medicines
BPMC
| $4.37M | 0.01% |
+68,400
| New | +$4.91M |
|
1697
Core Laboratories
CLB
$571M
| $4.37M | 0.01% |
138,100
+41,833
| +43% | +$1.17M |
|
|
KDNY
1698
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $4.36M | 0.01% |
266,742
-101,900
| -28% | -$1.39M |
|
|
DCBO
1699
Docebo
DCBO
$584M
| $4.36M | 0.01% |
84,200
+49,400
| +142% | +$2.54M |
|
|
MANT
1700
DELISTED
Mantech International Corp
MANT
| $4.35M | 0.01% |
+50,500
| New | +$4.03M |
|
Similar funds
Jim Simons's Q1 2022 Portfolio in Review
As of Q1 2022, Jim Simons held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.
- Jim Simons's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
- Jim Simons added most to Tesla in Q1 2022, an estimated $759M increase.
- Jim Simons's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
- Jim Simons fully exited Microsoft in Q1 2022, selling an estimated $786M.
- Jim Simons's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
- Jim Simons opened 822 new positions and closed 650 in Q1 2022.
- Jim Simons's portfolio value rose 6% quarter-over-quarter to $85.2B.
Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.